Home » Pfizer to Appeal India Decision to Revoke Cancer Drug Patent
Pfizer to Appeal India Decision to Revoke Cancer Drug Patent
Pfizer, the India unit of U.S. drugmaker Pfizer, will challenge the country’s patent office for revoking a patent for its cancer drug Sutent (sunitinib).
Reuters
Reuters
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May